In this Section |
226628 Implementing an Effective National HIV/AIDS Strategy: Recommendations from Black and Hispanic/Latino HIV/AIDS Investigators Working in Highly Affected Black and Hispanic/Latino CommunitiesTuesday, November 9, 2010
Issues: An estimated 1.1 million individuals in the US are living with HIV. Blacks and Hispanics/Latinos are disproportionately impacted by HIV, accounting for 27% of the US population and 62% of incident HIV cases (2006). In response to this crisis, the Office of National AIDS Policy (ONAP) is developing a National HIV/AIDS Strategy (NHAS). The primary goals of NHAS are to: 1) reduce the incidence of HIV; 2) increase access to care and optimize health outcomes; and 3) reduce HIV-related health disparities.
Description: During 2009, ONAP held town hall meetings across the US to invite public comment to help guide the development of NHAS. During the 2009 National HIV Prevention Conference, eight investigators funded through the Minority HIV/AIDS Research Initiative (MARI), a CDC-sponsored initiative that supports researchers conducting HIV/AIDS research in Black and Hispanic/Latino communities, met to respond to ONAP's call for public comment. Implications: MARI recommendations include: strengthening primary prevention in populations that have been largely overlooked in HIV prevention (e.g., youth of color, incarcerated persons, migrant and immigrant populations); providing comprehensive sex education in schools; providing universal health care for persons living with HIV/AIDS; increasing training opportunities for researchers and practitioners of color to diversify the HIV/AIDS workforce; matching federal funding to level of need in communities hardest hit by HIV/AIDS, and maintaining dialogue between affected communities and ONAP to facilitate feedback on NHAS progress.
Learning Areas:
Public health or related public policyPublic health or related research Learning Objectives:
Presenting author's disclosure statement:
Qualified on the content I am responsible for because: I was responsible for abstarct writing and analyses. I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines, and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed in my presentation.
Back to: 4101.0: Dialogue on Diversity in HIV/AIDS Issues 3
|